Maintenance Lurbinectedin in Combination With Serplulimab for Patients With ES-SCLC

Abroad (travel likely)RecruitingPHASE2

Conditions

Extensive-Stage Small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The first affiliated hospital of Guangzhou medical university, Guangzhou, Guangdong, China
Contact: Study coordinator (Liu, Doctor) · mingliu128@hotmail.com · 020-81566477

Study leads

chengzhi Zhou, MD
Principal Investigator
Guangzhou Institute of Respiratory Disease

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

MOnaliZumab in Combination With durvAlumab (MEDI4736) for tRreatmenT of Small Cell Lung Cancer

Small Cell Lung Cancer · SCLC · Extensive Stage Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Indianapolis, United States · Iowa City, United States

Durvalumab and Ablative Radiation in Small Cell Lung Cancer (DARES)

Small-cell Lung Cancer · Extensive-stage Small-cell Lung Cancer · Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Chicago, United States · Madison, United States

A Prospective, Single-Arm, Single-Center Phase II Study Evaluating the Efficacy and Safety of Chidamide Combined With PD-L1 Inhibitor, Carboplatin, and Etoposide as First-Line Treatment in Patients With Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)

Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Shenyang, China

Tislelizumab Combined With Chemotherapy and Relayed Radiotherapy in First-line Treatment of ES-SCLC

Extensive-stage Small Cell Lung Cancer (ES-SCLC)

Abroad (travel likely)RecruitingPHASE2

Hefei, China